Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Facebook Posts Point Sanofi To Change Allegra-D Foil Packaging

This article was originally published in The Pink Sheet Daily

Executive Summary

Sanofi changed the packaging design and the directions for removing the tablets after consumers stated on the brand’s Facebook page that they struggled with the foil blister packs. Chattem learned about and responded to the problem promptly through the two-way interaction that social media allows.

You may also be interested in...



Sanofi Allegra Switch Approval Triggers Race To Market For Perrigo

Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.

Prilosec OTC Packaging Change Gives Consumers Easier Access

Packaging changes for Procter & Gamble's Prilosec OTC proton-pump inhibitor are intended to make it easier to remove the product, according to brand executive Matt Champion

US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector

"It is just common sense that there's going to be fraud where you have the combination of high growth, developing science, imported products or ingredients and limited oversight," says David Morrell, deputy assistant US attorney in DoJ'd Consumer Protection Branch. CPB is adhering to executive order President Trump made earlier in 2019 instructing federal agencies to enforced based on regulations, not on guidance.

Topics

Related Companies

UsernamePublicRestriction

Register

PS073339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel